What is it?
Malignant hyperthermia is a drug-triggered genetic disorder of skeletal muscle. It is a hypermetabolic response to potent volatile anesthetic gases such as sevoflurane, desflurane and isoflurane, and to the muscle relaxant succinylcholine. Rarely, it is triggered by vigorous exercise or heat.Review1
The sevoflurane label warns that in susceptible people, volatile anesthetics may trigger it, causing a high oxygen demand. It also warns that fatal outcomes have been reported.Official text2
How is it inherited?
In humans it is inherited in an autosomal dominant pattern, meaning one copy of the gene change from one parent can be enough.Review1
Reactions are uncommon (1 in 10,000 to 1 in 250,000 anesthetics). But the genetic changes may be present in as many as 1 in 400 people.Review1
How is it treated?
Dantrolene is a specific antagonist and should be available wherever general anesthesia is given.Review1
The Ryanodex (dantrolene) label lists treatment of malignant hyperthermia with supportive measures, and prevention in people at high risk.Official text3
Questions you might bring to your anesthesia team
- Has anyone in my family had a problem with anesthesia, a high fever during surgery, or a diagnosis of malignant hyperthermia?
- If so, will my anesthesia avoid trigger agents?
- Should I or my family be referred for testing?